Results 101 to 110 of about 75,323 (218)

Locally Advanced Synchronous Hemorrhagic Gastric Cancer—From the First Symptom to Therapy—Case Report

open access: yesClinical Case Reports, Volume 14, Issue 4, April 2026.
ABSTRACT Gastric cancer is one of the most common malignancies worldwide, and its incidence shows global variability, with the highest rates reported in Eastern Asia, Eastern Europe, and South America due to the aging population and growth of high‐risk groups.
Szabolcs Attila Gabor   +5 more
wiley   +1 more source

Capecitabine-induced cicatricial ectropion: A case review

open access: yesThe Pan-American Journal of Ophthalmology
Capecitabine, an oral prodrug of 5-fluorouracil (5-FU), offers a more targeted chemotherapeutic approach, reducing systemic side effects. However, cases of ocular side effects have been described in the literature. We report the case of a 94-year-old man
Stuti Misty Tanya   +4 more
doaj   +1 more source

Ixabepilone as Monotherapy or in Combination with Capecitabine for the Treatment of Advanced Breast Cancer

open access: yesBreast Cancer: Basic and Clinical Research, 2011
Breast Cancer is the most prevalent cancer in the world with 4.4 million survivors up to 5 years following the diagnosis. 1 In the US alone approximately forty thousand women die annually of metastatic breast cancer (MBC). Despite many effective systemic
Katherine H. Rak Tkaczuk
doaj   +1 more source

Systemic 5-fluorouracil induced lupus erythematosus: a review of the literature [PDF]

open access: yes, 2019
Drug-induced subacute cutaneous lupus erythematosus (SCLE) is the most common subtype of drug-induced systemic lupus erythematosus and has been associated with more than 100 drugs.
Marsch, Amanda F, Shakhbazova, Anastasia
core  

Effect of First‐Line Chemotherapy Alone Versus First‐Line Chemotherapy Plus Radiotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer in the IMRT Era: A Retrospective Cohort Study

open access: yesCancer Reports, Volume 9, Issue 4, April 2026.
ABSTRACT Background The role of intensity‐modulated radiotherapy (IMRT) and novel combination chemotherapy regimens in locally advanced pancreatic cancer (LAPC) remains unclear. In this study, we focused on comparing survival between first‐line chemotherapy alone and first‐line chemotherapy plus IMRT in patients with LAPC.
Zihao Liu   +3 more
wiley   +1 more source

Multinuclear NMR Measurements and DFT Calculations for Capecitabine Tautomeric Form Assignment in a Solution

open access: yesMolecules, 2018
The molecular structure of capecitabine (a widely applied prodrug of 5-fluorouracil) was studied by multinuclear NMR measurements and DFT quantum mechanical calculations.
Piotr Cmoch   +2 more
doaj   +1 more source

Capecitabine-induced lichenoid drug eruption: a case report [PDF]

open access: yes, 2017
Capecitabine is a 5-fluorouracil basedchemotherapeutic drug widely used in the treatmentof solid tumors, especially colorectal and breast. Someof the most common side effects of capecitabine arecutaneous in nature, including hand-foot syndrome(palmar ...
Aouthmany, Mouhammad   +4 more
core  

Long‐term results of palliative placement of very low‐axial force self‐expandable metallic stents for malignant colorectal obstruction

open access: yesDEN Open, Volume 6, Issue 1, April 2026.
Abstract Objectives Stent placement is a standard option for palliative decompression in patients with malignant colorectal obstruction. Long‐term stent placement is associated with perforation, migration, and stent occlusion. Perforation is associated with life expectancy.
Rika Kyo   +12 more
wiley   +1 more source

Circulating Microbial Metabolites Predict Tumor Relapse and Chemotherapy Efficacy in Nasopharyngeal Carcinoma

open access: yesMedComm, Volume 7, Issue 4, April 2026.
ABSTRACT The value of microbial metabolites in prognosis and treatment response prediction in patients with nasopharyngeal carcinoma (NPC) remains unclear. Here, through the untargeted metabolomic analysis of plasma in 48 paired NPC patients with or without tumor relapse, we identified distinct circulating metabolite atlases between NPC patients with ...
Jun‐Yan Li   +16 more
wiley   +1 more source

Final results of a phase I/II pilot study of capecitabine with or without vinorelbine after sequential dose-dense epirubicin and paclitaxel in high-risk early breast cancer

open access: yesBMC Cancer, 2010
Background The integration of the non-cross-resistant chemotherapeutic agents capecitabine and vinorelbine into an intensified dose-dense sequential anthracycline- and taxane-containing regimen in high-risk early breast cancer (EBC) could improve ...
Müller Volkmar   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy